首页|小儿支原体肺炎患儿行阿奇霉素序贯疗法治疗的效果评价

小儿支原体肺炎患儿行阿奇霉素序贯疗法治疗的效果评价

扫码查看
目的 分析阿奇霉素序贯疗法治疗小儿支原体肺炎(mycoplasma pneumoniae pneumonia,MPP)患儿的效果.方法 方便选取2022年8月—2023年8月武威市凉州医院收治的274例MPP患儿为研究对象,根据不同治疗方案分为对照组和研究组,各137例.对照组采用注射乳糖酸红霉素治疗,研究组采用阿奇霉素序贯疗法,对比两组的临床疗效、症状消失时间、肺功能、炎症因子水平、不良反应发生情况.结果 研究组治疗总有效率为97.08%(133/137),高于对照组的89.05%(122/137),差异有统计学意义(χ2=6.843,P<0.05).研究组咳嗽、喘息、发热、肺啰音及胸闷消失时间均短于对照组,差异有统计学意义(P均<0.05).治疗前,两组肺功能对比,差异无统计学意义(P>0.05);治疗后,研究组肺功能水平高于对照组,差异有统计学意义(P<0.05).治疗前,两组炎性因子水平对比,差异无统计学意义(P>0.05);治疗后,研究组炎症因子水平低于对照组,差异有统计学意义(P<0.05).两组不良反应总发生率对比,差异无统计学意义(P>0.05).结论 阿奇霉素序贯疗法治疗小儿MPP患儿,有利于肺功能改善,减轻患儿炎症反应,并缩短症状消失时间,减少不良反应.
Effect of Sequential Azithromycin Therapy on Children with Mycoplasma Pneumonia
Objective To analyze the effect of azithromycin sequential therapy in the treatment of children with myco-plasma pneumoniae pneumonia(MPP).Methods A total of 274 children with MPP admitted to Wuwei Liangzhou Hos-pital from August 2022 to August 2023 were conveniently selected as the research objects.According to different treat-ment schemes,they were divided into control group and study group,with 137 cases in each group.The control group was treated with injection of erythromycin lactobionate,and the study group was treated with azithromycin sequential therapy.The clinical efficacy,symptom disappearance time,lung function,inflammatory factor levels,and adverse re-actions were compared between the two groups.Results The total effective rate of treatment in the study group was 97.08%(133/137),which was higher than 89.05%(122/137)of the control group,and the difference was statistically significant(χ2=6.843,P<0.05).The disappearance time of cough,wheezing,fever,pulmonary rales and chest tightness in the study group was shorter than that in the control group,and the differences were statistically significant(all P<0.05).Before treatment,there was no significant difference in lung function between the two groups(P>0.05);after treatment,the level of lung function in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in the levels of inflammatory factors between the two groups(P>0.05);after treatment,the level of inflammatory factors in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).The total incidence of adverse effects between the two groups,the difference was no statistically significant(P>0.05).Conclusion Azithromycin se-quential therapy in the treatment of children with MPP is beneficial to the improvement of lung function,reduce the in-flammatory response,shorten the disappearance time of symptoms,and have fewer adverse reactions.

Mycoplasma pneumoniaAzithromycinSequential therapyTherapeutic effectLung functionInflammatory factors

杜平、赵鹏、张立丽

展开 >

武威市凉州医院儿科,甘肃 武威 733000

支原体肺炎 阿奇霉素 序贯疗法 治疗效果 肺功能 炎症因子

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(32)